Companies: 10,795·Total market cap: $144.5T
Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc.

ACXPNASDAQHealthcare● Active
$1.62
$-0.06(-3.57%)
Market Cap$2567664
P/E Ratio
52W High$21
52W Low$1.326
Overview

Acurx Pharmaceuticals, Inc. (ACXP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ACXP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-4.91acxp eps ttm · acxp earnings per shareEarnings history
PE Ratio (TTM)acxp pe ratio ttm · acxp price to earningsPE Ratio deep dive
Revenue (TTM)0.00acxp revenue ttm · acxp annual revenueFull revenue history
Dividend YieldNo Dividenddoes acxp pay dividends · acxp dividend yieldDividend history
Shares Outstanding1.5Macxp shares outstanding · acxp floatShares outstanding history
Next EarningsAug 10, 2026Est.acxp earnings date · acxp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
acurx pharmaceuticals, inc. revenue · acxp revenue 2025
FY 2025Net Income-$8.0M▲ +43.51% YoY
202320242025
acurx pharmaceuticals, inc. net income · acxp profit 2025
FY 2025EPS$-5.32▲ +69.76% YoY
202320242025
acxp eps · acurx pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$7.5MEPS: $-4.91View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis acxp a buy · acxp analyst rating
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$1.62Current
$Avg Target
$High
acxp price target · acxp 12 month forecast

Total: 3 · Buy rate: 100.0%

Stock Performance

Full History
1D-3.57%
1W-13.83%
1M-22.49%
3M+20.00%
YTD-34.94%
1Y-75.82%
5Y-98.97%

About Acurx Pharmaceuticals, Inc.

CEODavid Luci
IPO DateJun 25, 2021
Employees4
CountryUS

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate i…

what is acurx pharmaceuticals, inc. · acxp stock overview · acurx pharmaceuticals, inc. company profile · who is acurx pharmaceuticals, inc. ceo · acxp NASDAQ · acurx pharmaceuticals, inc. headquarters · acurx pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Acurx Pharmaceuticals, Inc. (ACXP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 25, 2021. As of the latest trading session, ACXP stock price is $1.62, with a market capitalization of $2.6M. The stock has returned -75.82% over the past 12 months and -34.94% year-to-date.

According to 3 Wall Street analysts, the consensus rating for Acurx Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Acurx Pharmaceuticals, Inc. reported revenue of — and net income of -$8.0M. For detailed data — including Acurx Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Acurx Pharmaceuticals, Inc. (ACXP) stock price is $1.62. The stock is traded on NASDAQ under the ticker symbol ACXP. The 52-week range is $1.33 – $21.00.

ACXP stock priceACXP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice